'There are still a lot of unvaccinated people in poor countries and, once again, they are at the back of the line.'
"There are still a lot of unvaccinated people in poor countries and, once again, they are at the back of the line," said one expert.A coronavirus vaccine hailed as a potential solution to unequal access in poor countries is actually making the crisis worse as its U.S.-based manufacturer sends millions of doses to rich countries first, angering public health campaigners who say vaccine shortages in the developing world are prolonging the deadly pandemic.Thursday that Novavax, Inc.
"It's tragic that in year three of the pandemic, we still cannot get the resources, attention, and political will to solve vaccine inequity." "COVAX had planned to make available 250 million doses from Novavax by March, but the U.N. agency in charge of deliveries says the first shipments now likely won’t be made until April or May,"noted."It wasn't supposed to be this way. CEPI, one of the organizations leading COVAX, gave Novavax $388 million to fast-track the vaccine’s development, aimed at making the shot available in poorer countries as the pandemic was exploding two years ago.
"Countries including Zimbabwe, the Central African Republic, and Kiribati were among those in line to be offered Novavax doses by March from COVAX,"The protein-based shot was seen as a potentially significant tool in the fight against persistent vaccine inequity after it gained emergency approval late last year from the
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The six tragic errors the U.S. made that permitted Russia's war on UkraineOPINION: America and its allies committed six strategic errors that summoned aggression and ultimately let the Russia-Ukraine war degrade into a humanitarian tragedy, columnist pmorici1 writes.
Read more »
Moderna says its low-dose COVID shots work for kids under 6Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers
Read more »
Moderna says its low-dose COVID shots work for kids under 6Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose shots for youngsters under 6.
Read more »
Moderna says low-dose COVID-19 vaccine works in babies, young childrenModerna has announced has a COVID-19 vaccine that works in babies, toddlers and young children.
Read more »
Moderna says its Covid-19 vaccine performs as well in children as it does in adultsModerna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday.
Read more »
Moderna says its low-dose COVID shots work for kids under 6Moderna said its COVID-19 vaccine works in babies, toddlers and preschoolers, and if regulators agree, it could mean a chance to start vaccinating the littlest kids by summer.
Read more »